Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is
controversial. In addition, the association of vaccination with COVID-19–related VTE and …

Importance The incidence of arterial thromboembolism and venous thromboembolism in
persons with COVID-19 remains unclear. Objective To measure the 90-day risk of arterial …

Methods| We performed a retrospective cohort study of 220 588 adult members of the Kaiser
Permanente Northern California health plan who were tested for SARS-CoV-2 by …

Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
appear to be at increased risk for venous thromboembolism (VTE), especially if they become …

Objective To assess the associations between coronavirus disease 2019 (COVID-19)
infection and thromboembolism including myocardial infarction (MI), ischemic stroke, deep …

Importance COVID-19 is associated with a high incidence of thrombotic events; however, the
need for extended thromboprophylaxis after hospitalization remains unclear. Objective To …

Background COVID‐19 vaccinations in the United States are effective in preventing illness
and hospitalization yet concern over post‐vaccination venous thromboembolism (VTE) risk …

Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …

Background We aimed to identify the prevalence and predictors of venous
thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) …

Background Many studies confirmed an association between COVID-19 and venous
thromboembolism (VTE). Whether the risk of VTE significantly differed between COVID-19 …